As the president and CEO of Vir Biotechnology, as well as in his role as head of BIO’s Coronavirus Collaboration Initiative, George Scangos has emerged as a global leader in the fight against COVID-19. In this conversation with Stanford structural biology professor Jody Puglisi, Dr. Scangos explains the challenge of building financially viable therapies for infectious diseases, talks about the current status of COVID-related research, and explores how to build an innovative and meaningful career in biotech.
Related
Stephanie Lampkin,
Blendoor
Data-Powered Diversity [Entire Talk]
Data can be a powerful ally in building diverse organizations.
Stephanie Lampkin,
Blendoor
Data-Powered Diversity [Entire Talk]
Data can be a powerful ally in building diverse organizations.
Tony Mugavero,
Rad
Hype vs. Reality in VR [Entire Talk]
Connecting technological innovation to consumer demand requires flexibility, not certainty.
Tony Mugavero,
Rad
Hype vs. Reality in VR [Entire Talk]
Connecting technological innovation to consumer demand requires flexibility, not certainty.
Sarah Friar,
Nextdoor
Building Better Online Communities [Entire Talk]
How can you build respect into a social network?
Sarah Friar,
Nextdoor
Building Better Online Communities [Entire Talk]
How can you build respect into a social network?
